Phenoxypropazine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Phenoxypropazine
Accession Number
DB09251
Type
Small Molecule
Groups
Withdrawn
Description

Phenoxypropazine is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was introduced as an antidepressant in 1961, but was subsequently withdrawn in 1966 due to hepatotoxicity concerns.

Structure
Thumb
Synonyms
Not Available
International/Other Brands
Drazine
Categories
UNII
8E92V52324
CAS number
3818-37-9
Weight
Average: 166.224
Monoisotopic: 166.110613079
Chemical Formula
C9H14N2O
InChI Key
QNEXFJFTGQBXBJ-UHFFFAOYSA-N
InChI
InChI=1S/C9H14N2O/c1-8(11-10)7-12-9-5-3-2-4-6-9/h2-6,8,11H,7,10H2,1H3
IUPAC Name
(1-phenoxypropan-2-yl)hydrazine
SMILES
[H]N([H])N([H])C(C)COC1=CC=CC=C1

Pharmacology

Indication

For the treatment of depression.

Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
2,5-Dimethoxy-4-ethylamphetaminePhenoxypropazine may increase the hypertensive activities of 2,5-Dimethoxy-4-ethylamphetamine.Experimental, Illicit
3,4-MethylenedioxyamphetaminePhenoxypropazine may increase the hypertensive activities of 3,4-Methylenedioxyamphetamine.Experimental, Illicit
4-Bromo-2,5-dimethoxyamphetaminePhenoxypropazine may increase the hypertensive activities of 4-Bromo-2,5-dimethoxyamphetamine.Experimental, Illicit
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypertensive activities of Phenoxypropazine.Experimental
AcarbosePhenoxypropazine may increase the hypoglycemic activities of Acarbose.Approved, Investigational
AcebutololPhenoxypropazine may increase the hypotensive activities of Acebutolol.Approved
AlaproclateThe risk or severity of adverse effects can be increased when Alaproclate is combined with Phenoxypropazine.Experimental
AlbiglutidePhenoxypropazine may increase the hypoglycemic activities of Albiglutide.Approved
AlfentanilAlfentanil may increase the serotonergic activities of Phenoxypropazine.Approved, Illicit
AliskirenPhenoxypropazine may increase the hypotensive activities of Aliskiren.Approved, Investigational
AlmotriptanThe metabolism of Almotriptan can be decreased when combined with Phenoxypropazine.Approved, Investigational
AlogliptinPhenoxypropazine may increase the hypoglycemic activities of Alogliptin.Approved
AlphacetylmethadolThe risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Phenoxypropazine.Experimental, Illicit
AlphaprodineThe risk or severity of adverse effects can be increased when Alphaprodine is combined with Phenoxypropazine.Illicit
AlprenololPhenoxypropazine may increase the hypotensive activities of Alprenolol.Approved, Withdrawn
AltretamineAltretamine may increase the orthostatic hypotensive activities of Phenoxypropazine.Approved
AmbrisentanPhenoxypropazine may increase the hypotensive activities of Ambrisentan.Approved, Investigational
AmineptinePhenoxypropazine may increase the serotonergic activities of Amineptine.Illicit, Withdrawn
AmitriptylinePhenoxypropazine may increase the serotonergic activities of Amitriptyline.Approved
AmlodipinePhenoxypropazine may increase the hypotensive activities of Amlodipine.Approved
AmoxapineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Amoxapine.Approved
AmphetaminePhenoxypropazine may increase the hypertensive activities of Amphetamine.Approved, Illicit
ApomorphineThe metabolism of Apomorphine can be decreased when combined with Phenoxypropazine.Approved, Investigational
ApraclonidineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Apraclonidine.Approved
ArbutamineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Arbutamine.Approved
ArformoterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Arformoterol.Approved, Investigational
AtenololPhenoxypropazine may increase the hypotensive activities of Atenolol.Approved
AtomoxetinePhenoxypropazine may increase the central neurotoxic activities of Atomoxetine.Approved
AtropinePhenoxypropazine may increase the hypertensive activities of Atropine.Approved, Vet Approved
BambuterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Bambuterol.Approved, Investigational
BenazeprilPhenoxypropazine may increase the hypotensive activities of Benazepril.Approved, Investigational
BendroflumethiazidePhenoxypropazine may increase the hypotensive activities of Bendroflumethiazide.Approved
BenmoxinBenmoxin may increase the hypertensive activities of Phenoxypropazine.Withdrawn
BenzphetaminePhenoxypropazine may increase the hypertensive activities of Benzphetamine.Approved, Illicit
BepridilPhenoxypropazine may increase the hypotensive activities of Bepridil.Approved, Withdrawn
BetahistineThe serum concentration of Betahistine can be increased when it is combined with Phenoxypropazine.Approved
BetaxololPhenoxypropazine may increase the hypotensive activities of Betaxolol.Approved
BethanidinePhenoxypropazine may increase the hypotensive activities of Bethanidine.Approved
BezafibrateThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Bezafibrate.Approved
BietaserpinePhenoxypropazine may increase the hypotensive activities of Bietaserpine.Experimental
BimatoprostPhenoxypropazine may increase the hypotensive activities of Bimatoprost.Approved, Investigational
BisoprololPhenoxypropazine may increase the hypotensive activities of Bisoprolol.Approved
BosentanPhenoxypropazine may increase the hypotensive activities of Bosentan.Approved, Investigational
BQ-123Phenoxypropazine may increase the hypotensive activities of BQ-123.Investigational
BretyliumPhenoxypropazine may increase the hypotensive activities of Bretylium.Approved
BrimonidineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Brimonidine.Approved
BrofaromineBrofaromine may increase the hypertensive activities of Phenoxypropazine.Experimental
BromocriptinePhenoxypropazine may increase the hypoglycemic activities of Bromocriptine.Approved, Investigational
BupranololPhenoxypropazine may increase the hypotensive activities of Bupranolol.Approved
BuprenorphineThe risk or severity of adverse effects can be increased when Buprenorphine is combined with Phenoxypropazine.Approved, Illicit, Investigational, Vet Approved
BupropionPhenoxypropazine may increase the hypertensive activities of Bupropion.Approved
BuspironeThe risk or severity of adverse effects can be increased when Buspirone is combined with Phenoxypropazine.Approved, Investigational
ButorphanolThe risk or severity of adverse effects can be increased when Butorphanol is combined with Phenoxypropazine.Approved, Illicit, Vet Approved
CabergolineThe metabolism of Cabergoline can be decreased when combined with Phenoxypropazine.Approved
CadralazinePhenoxypropazine may increase the hypotensive activities of Cadralazine.Experimental
CafedrinePhenoxypropazine may increase the hypotensive activities of Cafedrine.Investigational
CanagliflozinPhenoxypropazine may increase the hypoglycemic activities of Canagliflozin.Approved
CandesartanPhenoxypropazine may increase the hypotensive activities of Candesartan.Experimental
Candesartan cilexetilPhenoxypropazine may increase the hypotensive activities of Candesartan cilexetil.Approved
CandoxatrilPhenoxypropazine may increase the hypotensive activities of Candoxatril.Experimental
CaptoprilPhenoxypropazine may increase the hypotensive activities of Captopril.Approved
CarbamazepineThe risk or severity of adverse effects can be increased when Carbamazepine is combined with Phenoxypropazine.Approved, Investigational
CarfentanilThe risk or severity of adverse effects can be increased when Carfentanil is combined with Phenoxypropazine.Illicit, Investigational, Vet Approved
CaroxazonePhenoxypropazine may increase the hypertensive activities of Caroxazone.Withdrawn
CarteololPhenoxypropazine may increase the hypotensive activities of Carteolol.Approved
CarvedilolPhenoxypropazine may increase the hypotensive activities of Carvedilol.Approved, Investigational
CeliprololPhenoxypropazine may increase the hypotensive activities of Celiprolol.Approved, Investigational
ChlorothiazidePhenoxypropazine may increase the hypotensive activities of Chlorothiazide.Approved, Vet Approved
ChlorphenterminePhenoxypropazine may increase the hypertensive activities of Chlorphentermine.Illicit, Withdrawn
ChlorpropamidePhenoxypropazine may increase the hypoglycemic activities of Chlorpropamide.Approved
ChlorthalidonePhenoxypropazine may increase the hypotensive activities of Chlorthalidone.Approved
CicletaninePhenoxypropazine may increase the hypotensive activities of Cicletanine.Investigational
CilazaprilPhenoxypropazine may increase the hypotensive activities of Cilazapril.Approved
CirazolinePhenoxypropazine may increase the hypertensive activities of Cirazoline.Experimental
CitalopramPhenoxypropazine may increase the serotonergic activities of Citalopram.Approved
ClemastinePhenoxypropazine may increase the anticholinergic activities of Clemastine.Approved
ClenbuterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Clenbuterol.Approved, Investigational, Vet Approved
ClomipraminePhenoxypropazine may increase the serotonergic activities of Clomipramine.Approved, Vet Approved
ClonidinePhenoxypropazine may increase the hypotensive activities of Clonidine.Approved
CloranololPhenoxypropazine may increase the hypotensive activities of Cloranolol.Experimental
CodeineThe risk or severity of adverse effects can be increased when Codeine is combined with Phenoxypropazine.Approved, Illicit
CryptenaminePhenoxypropazine may increase the hypotensive activities of Cryptenamine.Approved
CyclobenzaprineCyclobenzaprine may increase the serotonergic activities of Phenoxypropazine.Approved
CyclopenthiazidePhenoxypropazine may increase the hypotensive activities of Cyclopenthiazide.Experimental
CyclothiazidePhenoxypropazine may increase the hypotensive activities of Cyclothiazide.Approved
CyproheptadinePhenoxypropazine may increase the anticholinergic activities of Cyproheptadine.Approved
DapagliflozinPhenoxypropazine may increase the hypoglycemic activities of Dapagliflozin.Approved
DapoxetinePhenoxypropazine may increase the serotonergic activities of Dapoxetine.Investigational
DebrisoquinPhenoxypropazine may increase the hypotensive activities of Debrisoquin.Approved, Investigational
DelaprilPhenoxypropazine may increase the hypotensive activities of Delapril.Experimental
DeserpidinePhenoxypropazine may increase the hypotensive activities of Deserpidine.Approved
DesipraminePhenoxypropazine may increase the serotonergic activities of Desipramine.Approved
DesvenlafaxinePhenoxypropazine may increase the serotonergic activities of Desvenlafaxine.Approved
DexmethylphenidatePhenoxypropazine may increase the hypertensive activities of Dexmethylphenidate.Approved
DextroamphetaminePhenoxypropazine may increase the hypertensive activities of Dextroamphetamine.Approved, Illicit
DextromethorphanPhenoxypropazine may increase the serotonergic activities of Dextromethorphan.Approved
DextromoramideThe risk or severity of adverse effects can be increased when Dextromoramide is combined with Phenoxypropazine.Experimental, Illicit
DextropropoxypheneThe risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Phenoxypropazine.Approved, Illicit, Investigational, Withdrawn
DezocineThe risk or severity of adverse effects can be increased when Dezocine is combined with Phenoxypropazine.Approved, Investigational
DiazoxidePhenoxypropazine may increase the hypotensive activities of Diazoxide.Approved
DibenzepinPhenoxypropazine may increase the serotonergic activities of Dibenzepin.Experimental
diethylnorsperminePhenoxypropazine may increase the hypotensive activities of diethylnorspermine.Investigational
DiethylpropionPhenoxypropazine may increase the hypertensive activities of Diethylpropion.Approved, Illicit
DihydralazinePhenoxypropazine may increase the hypotensive activities of Dihydralazine.Investigational
DihydrocodeineThe risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Phenoxypropazine.Approved, Illicit
DihydroergotamineThe metabolism of Dihydroergotamine can be decreased when combined with Phenoxypropazine.Approved
DihydroetorphineThe risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Phenoxypropazine.Experimental, Illicit
DihydromorphineThe risk or severity of adverse effects can be increased when Dihydromorphine is combined with Phenoxypropazine.Experimental, Illicit
DiltiazemPhenoxypropazine may increase the hypotensive activities of Diltiazem.Approved
DiphenoxylateThe risk or severity of adverse effects can be increased when Diphenoxylate is combined with Phenoxypropazine.Approved, Illicit
DipivefrinThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Dipivefrin.Approved
DisopyramidePhenoxypropazine may increase the hypoglycemic activities of Disopyramide.Approved
DobutamineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Dobutamine.Approved
DomperidoneThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Domperidone.Approved, Investigational, Vet Approved
DorzolamidePhenoxypropazine may increase the hypotensive activities of Dorzolamide.Approved
DosulepinPhenoxypropazine may increase the serotonergic activities of Dosulepin.Approved
DoxapramPhenoxypropazine may increase the hypertensive activities of Doxapram.Approved, Vet Approved
DoxazosinPhenoxypropazine may increase the hypotensive activities of Doxazosin.Approved
DoxepinPhenoxypropazine may increase the serotonergic activities of Doxepin.Approved
DoxylaminePhenoxypropazine may increase the anticholinergic activities of Doxylamine.Approved, Vet Approved
DPDPEThe risk or severity of adverse effects can be increased when DPDPE is combined with Phenoxypropazine.Experimental
DrotebanolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Phenoxypropazine.Experimental, Illicit
DroxidopaThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Droxidopa.Approved, Investigational
DulaglutidePhenoxypropazine may increase the hypoglycemic activities of Dulaglutide.Approved
DuloxetinePhenoxypropazine may increase the serotonergic activities of Duloxetine.Approved
EcgonineThe risk or severity of adverse effects can be increased when Ecgonine is combined with Phenoxypropazine.Experimental, Illicit
EfonidipinePhenoxypropazine may increase the hypotensive activities of Efonidipine.Approved, Investigational
EletriptanThe metabolism of Eletriptan can be decreased when combined with Phenoxypropazine.Approved, Investigational
EmpagliflozinPhenoxypropazine may increase the hypoglycemic activities of Empagliflozin.Approved
EnalaprilPhenoxypropazine may increase the hypotensive activities of Enalapril.Approved, Vet Approved
EnalaprilatPhenoxypropazine may increase the hypotensive activities of Enalaprilat.Approved
EndralazinePhenoxypropazine may increase the hypotensive activities of Endralazine.Experimental
EntacaponeThe risk or severity of adverse effects can be increased when Entacapone is combined with Phenoxypropazine.Approved, Investigational
EpanololPhenoxypropazine may increase the hypotensive activities of Epanolol.Experimental
EphedraThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Ephedra.Approved, Nutraceutical, Withdrawn
EpinephrinePhenoxypropazine may increase the hypertensive activities of Epinephrine.Approved, Vet Approved
EpoprostenolPhenoxypropazine may increase the hypotensive activities of Epoprostenol.Approved
EprosartanPhenoxypropazine may increase the hypotensive activities of Eprosartan.Approved
ErgotaminePhenoxypropazine may increase the hypertensive activities of Ergotamine.Approved
EscitalopramPhenoxypropazine may increase the serotonergic activities of Escitalopram.Approved, Investigational
EsmirtazapinePhenoxypropazine may increase the serotonergic activities of Esmirtazapine.Investigational
EthanolThe risk or severity of adverse effects can be increased when Ethanol is combined with Phenoxypropazine.Approved
EthylmorphineThe risk or severity of adverse effects can be increased when Ethylmorphine is combined with Phenoxypropazine.Approved, Illicit
EtoperidonePhenoxypropazine may increase the serotonergic activities of Etoperidone.Withdrawn
EtorphineThe risk or severity of adverse effects can be increased when Etorphine is combined with Phenoxypropazine.Illicit, Vet Approved
ExenatidePhenoxypropazine may increase the hypoglycemic activities of Exenatide.Approved, Investigational
FelodipinePhenoxypropazine may increase the hypotensive activities of Felodipine.Approved, Investigational
FenfluramineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Fenfluramine.Illicit, Investigational, Withdrawn
FenoldopamPhenoxypropazine may increase the hypotensive activities of Fenoldopam.Approved
FenoterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Fenoterol.Approved, Investigational
FentanylFentanyl may increase the serotonergic activities of Phenoxypropazine.Approved, Illicit, Investigational, Vet Approved
Ferulic acidPhenoxypropazine may increase the hypotensive activities of Ferulic acid.Experimental
FluoxetinePhenoxypropazine may increase the serotonergic activities of Fluoxetine.Approved, Vet Approved
FluvoxaminePhenoxypropazine may increase the serotonergic activities of Fluvoxamine.Approved, Investigational
FormoterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Formoterol.Approved, Investigational
FosinoprilPhenoxypropazine may increase the hypotensive activities of Fosinopril.Approved
FrovatriptanThe metabolism of Frovatriptan can be decreased when combined with Phenoxypropazine.Approved, Investigational
FurazolidoneFurazolidone may increase the hypertensive activities of Phenoxypropazine.Approved, Investigational, Vet Approved
GepefrineThe risk or severity of adverse effects can be increased when Gepefrine is combined with Phenoxypropazine.Experimental
GliclazidePhenoxypropazine may increase the hypoglycemic activities of Gliclazide.Approved
GlimepiridePhenoxypropazine may increase the hypoglycemic activities of Glimepiride.Approved
GlipizidePhenoxypropazine may increase the hypoglycemic activities of Glipizide.Approved
GlyburidePhenoxypropazine may increase the hypoglycemic activities of Glyburide.Approved
GuanabenzPhenoxypropazine may increase the hypotensive activities of Guanabenz.Approved, Investigational
GuanadrelPhenoxypropazine may increase the hypotensive activities of Guanadrel.Approved
GuanazodinePhenoxypropazine may increase the hypotensive activities of Guanazodine.Experimental
GuanethidinePhenoxypropazine may increase the hypotensive activities of Guanethidine.Approved
GuanfacinePhenoxypropazine may increase the hypotensive activities of Guanfacine.Approved, Investigational
GuanoclorPhenoxypropazine may increase the hypotensive activities of Guanoclor.Experimental
GuanoxabenzPhenoxypropazine may increase the hypotensive activities of Guanoxabenz.Experimental
GuanoxanPhenoxypropazine may increase the hypotensive activities of Guanoxan.Experimental
HarmalineHarmaline may increase the hypertensive activities of Phenoxypropazine.Experimental
HeroinThe risk or severity of adverse effects can be increased when Heroin is combined with Phenoxypropazine.Approved, Illicit, Investigational
HexamethoniumPhenoxypropazine may increase the hypotensive activities of Hexamethonium.Experimental
HydracarbazineHydracarbazine may increase the hypertensive activities of Phenoxypropazine.Experimental
HydralazinePhenoxypropazine may increase the hypotensive activities of Hydralazine.Approved
HydrochlorothiazidePhenoxypropazine may increase the hypotensive activities of Hydrochlorothiazide.Approved, Vet Approved
HydrocodoneThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Hydrocodone.Approved, Illicit
HydroflumethiazidePhenoxypropazine may increase the hypotensive activities of Hydroflumethiazide.Approved, Investigational
HydromorphoneThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Hydromorphone.Approved, Illicit
HydroxyamphetaminePhenoxypropazine may increase the hypertensive activities of Hydroxyamphetamine.Approved
ImidaprilPhenoxypropazine may increase the hypotensive activities of Imidapril.Investigational
ImipraminePhenoxypropazine may increase the serotonergic activities of Imipramine.Approved
IndacaterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Indacaterol.Approved
IndalpinePhenoxypropazine may increase the serotonergic activities of Indalpine.Investigational, Withdrawn
IndapamidePhenoxypropazine may increase the hypotensive activities of Indapamide.Approved
IndenololPhenoxypropazine may increase the hypotensive activities of Indenolol.Withdrawn
IndoraminPhenoxypropazine may increase the hypotensive activities of Indoramin.Withdrawn
Insulin AspartPhenoxypropazine may increase the hypoglycemic activities of Insulin Aspart.Approved
Insulin DetemirPhenoxypropazine may increase the hypoglycemic activities of Insulin Detemir.Approved
Insulin GlarginePhenoxypropazine may increase the hypoglycemic activities of Insulin Glargine.Approved
Insulin GlulisinePhenoxypropazine may increase the hypoglycemic activities of Insulin Glulisine.Approved
Insulin HumanPhenoxypropazine may increase the hypoglycemic activities of Insulin Human.Approved, Investigational
Insulin LisproPhenoxypropazine may increase the hypoglycemic activities of Insulin Lispro.Approved
Iofetamine I-123The risk or severity of adverse effects can be increased when Iofetamine I-123 is combined with Phenoxypropazine.Approved
IprindolePhenoxypropazine may increase the serotonergic activities of Iprindole.Experimental
IproclozideIproclozide may increase the hypertensive activities of Phenoxypropazine.Withdrawn
IproniazidIproniazid may increase the hypertensive activities of Phenoxypropazine.Withdrawn
IrbesartanPhenoxypropazine may increase the hypotensive activities of Irbesartan.Approved, Investigational
IsocarboxazidIsocarboxazid may increase the hypertensive activities of Phenoxypropazine.Approved
IsoetarineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Isoetarine.Approved
IsomethepteneThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Isometheptene.Approved
IsoprenalineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Isoprenaline.Approved
IsradipinePhenoxypropazine may increase the hypotensive activities of Isradipine.Approved
KetanserinPhenoxypropazine may increase the hypotensive activities of Ketanserin.Investigational
KetobemidoneThe risk or severity of adverse effects can be increased when Ketobemidone is combined with Phenoxypropazine.Approved, Investigational
L-TryptophanThe risk or severity of adverse effects can be increased when L-Tryptophan is combined with Phenoxypropazine.Approved, Nutraceutical, Withdrawn
LabetalolPhenoxypropazine may increase the hypotensive activities of Labetalol.Approved
LacidipinePhenoxypropazine may increase the hypotensive activities of Lacidipine.Approved, Investigational
LatanoprostPhenoxypropazine may increase the hypotensive activities of Latanoprost.Approved, Investigational
LercanidipinePhenoxypropazine may increase the hypotensive activities of Lercanidipine.Approved, Investigational
LevodopaThe risk or severity of adverse effects can be increased when Levodopa is combined with Phenoxypropazine.Approved
Levomethadyl AcetateThe risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Phenoxypropazine.Approved, Investigational
LevomilnacipranPhenoxypropazine may increase the serotonergic activities of Levomilnacipran.Approved
LevonordefrinPhenoxypropazine may increase the hypertensive activities of Levonordefrin.Approved
LevorphanolThe risk or severity of adverse effects can be increased when Levorphanol is combined with Phenoxypropazine.Approved
LevosalbutamolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Levosalbutamol.Approved
LinezolidThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Linezolid.Approved, Investigational
LinsidominePhenoxypropazine may increase the hypotensive activities of Linsidomine.Experimental
LiraglutidePhenoxypropazine may increase the hypoglycemic activities of Liraglutide.Approved
LisdexamfetaminePhenoxypropazine may increase the hypertensive activities of Lisdexamfetamine.Approved, Investigational
LisinoprilPhenoxypropazine may increase the hypotensive activities of Lisinopril.Approved, Investigational
LisurideThe metabolism of Lisuride can be decreased when combined with Phenoxypropazine.Approved, Investigational
LithiumThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Lithium.Approved
LofentanilThe risk or severity of adverse effects can be increased when Lofentanil is combined with Phenoxypropazine.Illicit
LofepraminePhenoxypropazine may increase the serotonergic activities of Lofepramine.Experimental
LofexidinePhenoxypropazine may increase the hypotensive activities of Lofexidine.Approved, Investigational
LosartanPhenoxypropazine may increase the hypotensive activities of Losartan.Approved
MacitentanPhenoxypropazine may increase the hypotensive activities of Macitentan.Approved
ManidipinePhenoxypropazine may increase the hypotensive activities of Manidipine.Approved, Investigational
MaprotilineThe risk or severity of adverse effects can be increased when Maprotiline is combined with Phenoxypropazine.Approved
MebanazineMebanazine may increase the hypertensive activities of Phenoxypropazine.Withdrawn
MecamylaminePhenoxypropazine may increase the hypotensive activities of Mecamylamine.Approved
MecaserminPhenoxypropazine may increase the hypoglycemic activities of Mecasermin.Approved, Investigational
MephedronePhenoxypropazine may increase the hypertensive activities of Mephedrone.Investigational
MephenterminePhenoxypropazine may increase the hypertensive activities of Mephentermine.Approved
MeptazinolThe risk or severity of adverse effects can be increased when Meptazinol is combined with Phenoxypropazine.Experimental
MequitazinePhenoxypropazine may increase the anticholinergic activities of Mequitazine.Approved
MetaraminolPhenoxypropazine may increase the hypertensive activities of Metaraminol.Approved, Investigational
MetforminPhenoxypropazine may increase the hypoglycemic activities of Metformin.Approved
MethadoneThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Methadone.Approved
Methadyl AcetateThe risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Phenoxypropazine.Approved, Illicit
MethamphetaminePhenoxypropazine may increase the hypertensive activities of Methamphetamine.Approved, Illicit
MethoserpidinePhenoxypropazine may increase the hypotensive activities of Methoserpidine.Experimental
MethoxaminePhenoxypropazine may increase the hypertensive activities of Methoxamine.Approved, Investigational
MethoxyphenamineThe risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Phenoxypropazine.Experimental
MethyldopaThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Methyldopa.Approved
MethylecgonineThe risk or severity of adverse effects can be increased when Methylecgonine is combined with Phenoxypropazine.Experimental
Methylene bluePhenoxypropazine may increase the serotonergic activities of Methylene blue.Approved, Investigational
MethylphenidatePhenoxypropazine may increase the hypertensive activities of Methylphenidate.Approved, Investigational
MetipranololPhenoxypropazine may increase the hypotensive activities of Metipranolol.Approved
MetolazonePhenoxypropazine may increase the hypotensive activities of Metolazone.Approved
MetoprololPhenoxypropazine may increase the hypotensive activities of Metoprolol.Approved, Investigational
MetyrosinePhenoxypropazine may increase the hypotensive activities of Metyrosine.Approved
MianserinPhenoxypropazine may increase the neurotoxic activities of Mianserin.Approved, Investigational
MibefradilPhenoxypropazine may increase the hypotensive activities of Mibefradil.Investigational, Withdrawn
MidodrinePhenoxypropazine may increase the hypertensive activities of Midodrine.Approved
MidomafetaminePhenoxypropazine may increase the hypertensive activities of Midomafetamine.Experimental, Illicit, Investigational
MifepristonePhenoxypropazine may increase the hypoglycemic activities of Mifepristone.Approved, Investigational
MiglitolPhenoxypropazine may increase the hypoglycemic activities of Miglitol.Approved
MilnacipranPhenoxypropazine may increase the serotonergic activities of Milnacipran.Approved
MinaprineMinaprine may increase the hypertensive activities of Phenoxypropazine.Approved
MinoxidilPhenoxypropazine may increase the hypotensive activities of Minoxidil.Approved
MirtazapinePhenoxypropazine may increase the central neurotoxic activities of Mirtazapine.Approved
MMDAPhenoxypropazine may increase the hypertensive activities of MMDA.Experimental, Illicit
MoclobemideThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Moclobemide.Approved
MoexiprilPhenoxypropazine may increase the hypotensive activities of Moexipril.Approved
MorphineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Morphine.Approved, Investigational
MoxonidinePhenoxypropazine may increase the hypotensive activities of Moxonidine.Approved, Investigational
MuzoliminePhenoxypropazine may increase the hypotensive activities of Muzolimine.Experimental
NadololPhenoxypropazine may increase the hypotensive activities of Nadolol.Approved
NaftopidilPhenoxypropazine may increase the hypotensive activities of Naftopidil.Investigational
NalbuphineThe risk or severity of adverse effects can be increased when Nalbuphine is combined with Phenoxypropazine.Approved
NaratriptanThe metabolism of Naratriptan can be decreased when combined with Phenoxypropazine.Approved, Investigational
NateglinidePhenoxypropazine may increase the hypoglycemic activities of Nateglinide.Approved, Investigational
NebivololPhenoxypropazine may increase the hypotensive activities of Nebivolol.Approved, Investigational
NefazodonePhenoxypropazine may increase the serotonergic activities of Nefazodone.Approved, Withdrawn
NialamideNialamide may increase the hypertensive activities of Phenoxypropazine.Withdrawn
NicardipinePhenoxypropazine may increase the hypotensive activities of Nicardipine.Approved
NicorandilPhenoxypropazine may increase the hypotensive activities of Nicorandil.Approved, Investigational
NiguldipinePhenoxypropazine may increase the hypotensive activities of Niguldipine.Experimental
NilvadipinePhenoxypropazine may increase the hypotensive activities of Nilvadipine.Approved, Investigational
NimodipinePhenoxypropazine may increase the hypotensive activities of Nimodipine.Approved
NisoldipinePhenoxypropazine may increase the hypotensive activities of Nisoldipine.Approved
NitrendipinePhenoxypropazine may increase the hypotensive activities of Nitrendipine.Approved, Investigational
NitroprussidePhenoxypropazine may increase the hypotensive activities of Nitroprusside.Approved
NorepinephrinePhenoxypropazine may increase the hypertensive activities of Norepinephrine.Approved
NormethadoneThe risk or severity of adverse effects can be increased when Normethadone is combined with Phenoxypropazine.Approved, Illicit
NortriptylinePhenoxypropazine may increase the serotonergic activities of Nortriptyline.Approved
OctamoxinOctamoxin may increase the hypertensive activities of Phenoxypropazine.Withdrawn
OlanzapineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Olanzapine.Approved, Investigational
OlmesartanPhenoxypropazine may increase the hypotensive activities of Olmesartan.Approved, Investigational
OlodaterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Olodaterol.Approved
OmapatrilatPhenoxypropazine may increase the hypotensive activities of Omapatrilat.Investigational
OpipramolPhenoxypropazine may increase the serotonergic activities of Opipramol.Investigational
OpiumThe risk or severity of adverse effects can be increased when Opium is combined with Phenoxypropazine.Approved, Illicit
OrciprenalineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Orciprenaline.Approved
OxprenololPhenoxypropazine may increase the hypotensive activities of Oxprenolol.Approved
OxycodoneThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Oxycodone.Approved, Illicit, Investigational
OxymorphoneThe risk or severity of adverse effects can be increased when Oxymorphone is combined with Phenoxypropazine.Approved, Investigational, Vet Approved
PargylinePhenoxypropazine may increase the hypotensive activities of Pargyline.Approved
ParoxetinePhenoxypropazine may increase the serotonergic activities of Paroxetine.Approved, Investigational
PenbutololPhenoxypropazine may increase the hypotensive activities of Penbutolol.Approved, Investigational
PentamidinePhenoxypropazine may increase the hypoglycemic activities of Pentamidine.Approved
PentazocineThe risk or severity of adverse effects can be increased when Pentazocine is combined with Phenoxypropazine.Approved, Vet Approved
PentoliniumPhenoxypropazine may increase the hypotensive activities of Pentolinium.Approved
PergolideThe metabolism of Pergolide can be decreased when combined with Phenoxypropazine.Approved, Investigational, Vet Approved, Withdrawn
PerindoprilPhenoxypropazine may increase the hypotensive activities of Perindopril.Approved
PethidinePhenoxypropazine may increase the serotonergic activities of Pethidine.Approved
PhenazocineThe risk or severity of adverse effects can be increased when Phenazocine is combined with Phenoxypropazine.Experimental
PhenelzinePhenelzine may increase the hypertensive activities of Phenoxypropazine.Approved
PheniprazinePheniprazine may increase the hypertensive activities of Phenoxypropazine.Withdrawn
PhenoperidineThe risk or severity of adverse effects can be increased when Phenoperidine is combined with Phenoxypropazine.Experimental
PhenoxybenzaminePhenoxypropazine may increase the hypotensive activities of Phenoxybenzamine.Approved
PhenterminePhenoxypropazine may increase the hypertensive activities of Phentermine.Approved, Illicit
PhentolaminePhenoxypropazine may increase the hypotensive activities of Phentolamine.Approved
PhenylephrinePhenoxypropazine may increase the hypertensive activities of Phenylephrine.Approved
PhenylpropanolamineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Phenylpropanolamine.Approved, Vet Approved, Withdrawn
PholcodinePholcodine may increase the serotonergic activities of Phenoxypropazine.Approved, Illicit
PiclozotanThe metabolism of Piclozotan can be decreased when combined with Phenoxypropazine.Investigational
PinacidilPhenoxypropazine may increase the hypotensive activities of Pinacidil.Withdrawn
PindololPhenoxypropazine may increase the hypotensive activities of Pindolol.Approved
PioglitazonePhenoxypropazine may increase the hypoglycemic activities of Pioglitazone.Approved, Investigational
PirbuterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Pirbuterol.Approved
PiritramideThe risk or severity of adverse effects can be increased when Piritramide is combined with Phenoxypropazine.Investigational
PirlindolePirlindole may increase the hypertensive activities of Phenoxypropazine.Approved
PivhydrazinePhenoxypropazine may increase the hypertensive activities of Pivhydrazine.Withdrawn
PizotifenPhenoxypropazine may increase the anticholinergic activities of Pizotifen.Approved
Platelet Activating FactorPhenoxypropazine may increase the hypotensive activities of Platelet Activating Factor.Experimental
PolythiazidePhenoxypropazine may increase the hypotensive activities of Polythiazide.Approved
PramlintidePhenoxypropazine may increase the hypoglycemic activities of Pramlintide.Approved, Investigational
PrazosinPhenoxypropazine may increase the hypotensive activities of Prazosin.Approved
ProcarbazineProcarbazine may increase the hypertensive activities of Phenoxypropazine.Approved
ProcaterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Procaterol.Approved, Investigational
PropranololPhenoxypropazine may increase the hypotensive activities of Propranolol.Approved, Investigational
ProtriptylinePhenoxypropazine may increase the serotonergic activities of Protriptyline.Approved
PRX-00023The metabolism of PRX-00023 can be decreased when combined with Phenoxypropazine.Investigational
PseudoephedrinePhenoxypropazine may increase the hypertensive activities of Pseudoephedrine.Approved
QuinaprilPhenoxypropazine may increase the hypotensive activities of Quinapril.Approved, Investigational
QuininePhenoxypropazine may increase the hypoglycemic activities of Quinine.Approved
RamiprilPhenoxypropazine may increase the hypotensive activities of Ramipril.Approved
RasagilineRasagiline may increase the hypertensive activities of Phenoxypropazine.Approved
RemifentanilRemifentanil may increase the serotonergic activities of Phenoxypropazine.Approved
RemikirenPhenoxypropazine may increase the hypotensive activities of Remikiren.Approved
RepaglinidePhenoxypropazine may increase the hypoglycemic activities of Repaglinide.Approved, Investigational
RescinnaminePhenoxypropazine may increase the hypotensive activities of Rescinnamine.Approved
ReserpineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Reserpine.Approved, Investigational
RilmenidinePhenoxypropazine may increase the hypotensive activities of Rilmenidine.Investigational
RiociguatPhenoxypropazine may increase the hypotensive activities of Riociguat.Approved
RitobegronPhenoxypropazine may increase the hypertensive activities of Ritobegron.Investigational
RitodrineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Ritodrine.Approved, Investigational
RizatriptanThe metabolism of Rizatriptan can be decreased when combined with Phenoxypropazine.Approved
RopiniroleThe metabolism of Ropinirole can be decreased when combined with Phenoxypropazine.Approved, Investigational
RosiglitazonePhenoxypropazine may increase the hypoglycemic activities of Rosiglitazone.Approved, Investigational
SafrazinePhenoxypropazine may increase the hypertensive activities of Safrazine.Withdrawn
SalbutamolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Salbutamol.Approved, Vet Approved
SalmeterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Salmeterol.Approved
SaprisartanPhenoxypropazine may increase the hypotensive activities of Saprisartan.Experimental
SaxagliptinPhenoxypropazine may increase the hypoglycemic activities of Saxagliptin.Approved
SelegilineSelegiline may increase the hypertensive activities of Phenoxypropazine.Approved, Investigational, Vet Approved
SelexipagPhenoxypropazine may increase the hypotensive activities of Selexipag.Approved
SertralinePhenoxypropazine may increase the serotonergic activities of Sertraline.Approved
SitagliptinPhenoxypropazine may increase the hypoglycemic activities of Sitagliptin.Approved, Investigational
SitaxentanPhenoxypropazine may increase the hypotensive activities of Sitaxentan.Approved, Investigational, Withdrawn
SpiraprilPhenoxypropazine may increase the hypotensive activities of Spirapril.Approved
SufentanilSufentanil may increase the serotonergic activities of Phenoxypropazine.Approved, Investigational
SulfadiazinePhenoxypropazine may increase the hypoglycemic activities of Sulfadiazine.Approved, Vet Approved
SulfamethoxazolePhenoxypropazine may increase the hypoglycemic activities of Sulfamethoxazole.Approved
SulfisoxazolePhenoxypropazine may increase the hypoglycemic activities of Sulfisoxazole.Approved, Vet Approved
SumatriptanThe metabolism of Sumatriptan can be decreased when combined with Phenoxypropazine.Approved, Investigational
SunitinibPhenoxypropazine may increase the hypoglycemic activities of Sunitinib.Approved, Investigational
TalinololPhenoxypropazine may increase the hypotensive activities of Talinolol.Investigational
TapentadolThe risk or severity of adverse effects can be increased when Tapentadol is combined with Phenoxypropazine.Approved
TelmisartanPhenoxypropazine may increase the hypotensive activities of Telmisartan.Approved, Investigational
TemocaprilPhenoxypropazine may increase the hypotensive activities of Temocapril.Experimental, Investigational
TerbutalineThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Terbutaline.Approved
TerlipressinPhenoxypropazine may increase the hypotensive activities of Terlipressin.Approved, Investigational
Testosterone PropionateThe risk or severity of adverse effects can be increased when Testosterone Propionate is combined with Phenoxypropazine.Approved, Vet Approved
TetrabenazineThe risk or severity of adverse effects can be increased when Tetrabenazine is combined with Phenoxypropazine.Approved
TetrahydropalmatinePhenoxypropazine may increase the hypotensive activities of Tetrahydropalmatine.Investigational
TetryzolinePhenoxypropazine may increase the hypertensive activities of Tetryzoline.Approved
TheodrenalinePhenoxypropazine may increase the hypotensive activities of Theodrenaline.Investigational
TianeptineThe risk or severity of adverse effects can be increased when Tianeptine is combined with Phenoxypropazine.Approved, Investigational
TibolonePhenoxypropazine may increase the hypotensive activities of Tibolone.Approved, Investigational
TicrynafenPhenoxypropazine may increase the hypotensive activities of Ticrynafen.Withdrawn
TilidineThe risk or severity of adverse effects can be increased when Tilidine is combined with Phenoxypropazine.Experimental
TimololPhenoxypropazine may increase the hypotensive activities of Timolol.Approved
TolazamidePhenoxypropazine may increase the hypoglycemic activities of Tolazamide.Approved
TolazolinePhenoxypropazine may increase the hypotensive activities of Tolazoline.Approved, Vet Approved
TolbutamidePhenoxypropazine may increase the hypoglycemic activities of Tolbutamide.Approved
TolcaponeThe risk or severity of adverse effects can be increased when Tolcapone is combined with Phenoxypropazine.Approved, Withdrawn
TolonidinePhenoxypropazine may increase the hypotensive activities of Tolonidine.Experimental
ToloxatoneToloxatone may increase the hypertensive activities of Phenoxypropazine.Approved
TorasemidePhenoxypropazine may increase the hypotensive activities of Torasemide.Approved
TramadolTramadol may increase the neuroexcitatory activities of Phenoxypropazine.Approved, Investigational
TrandolaprilPhenoxypropazine may increase the hypotensive activities of Trandolapril.Approved
Trans-2-PhenylcyclopropylamineTrans-2-Phenylcyclopropylamine may increase the hypertensive activities of Phenoxypropazine.Experimental
TranylcypromineTranylcypromine may increase the hypertensive activities of Phenoxypropazine.Approved
TravoprostPhenoxypropazine may increase the hypotensive activities of Travoprost.Approved
TrazodoneThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Trazodone.Approved, Investigational
TreprostinilPhenoxypropazine may increase the hypotensive activities of Treprostinil.Approved, Investigational
TrichlormethiazidePhenoxypropazine may increase the hypotensive activities of Trichlormethiazide.Approved, Vet Approved
TrimazosinPhenoxypropazine may increase the hypotensive activities of Trimazosin.Experimental
TrimethaphanPhenoxypropazine may increase the hypotensive activities of Trimethaphan.Approved, Investigational
TrimipraminePhenoxypropazine may increase the serotonergic activities of Trimipramine.Approved
UnoprostonePhenoxypropazine may increase the hypotensive activities of Unoprostone.Approved
UrapidilPhenoxypropazine may increase the hypotensive activities of Urapidil.Investigational
ValsartanPhenoxypropazine may increase the hypotensive activities of Valsartan.Approved, Investigational
VenlafaxinePhenoxypropazine may increase the serotonergic activities of Venlafaxine.Approved
VilanterolThe risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Vilanterol.Approved
VilazodoneThe metabolism of Vilazodone can be decreased when combined with Phenoxypropazine.Approved
VincaminePhenoxypropazine may increase the hypotensive activities of Vincamine.Experimental
VinpocetinePhenoxypropazine may increase the hypotensive activities of Vinpocetine.Investigational
VortioxetineThe metabolism of Vortioxetine can be decreased when combined with Phenoxypropazine.Approved
XipamidePhenoxypropazine may increase the hypotensive activities of Xipamide.Experimental
XylometazolinePhenoxypropazine may increase the hypotensive activities of Xylometazoline.Approved
ZimelidinePhenoxypropazine may increase the serotonergic activities of Zimelidine.Withdrawn
ZofenoprilPhenoxypropazine may increase the hypotensive activities of Zofenopril.Experimental
ZolmitriptanThe metabolism of Zolmitriptan can be decreased when combined with Phenoxypropazine.Approved, Investigational
Food Interactions
Not Available

References

General References
  1. LEAHY MR, ROSE JT, PLOWMAN R: A preliminary study of phenoxypropazine in the treatment of depression. Am J Psychiatry. 1963 Apr;119:986-7. [PubMed:13928824]
  2. IMLAH NW: Preliminary report on phenoxypropazine. Am J Psychiatry. 1963 May;119:1091-2. [PubMed:13956423]
  3. ROSE JT, LEAHY MR, PLOWMAN R: A COMPARISON OF PHENOXYPROPAZINE AND AMYTRYPTILINE IN DEPRESSION. Am J Psychiatry. 1963 Oct;120:393-5. [PubMed:14069469]
External Links
PubChem Compound
71467
PubChem Substance
310265154
ChemSpider
64548
ChEBI
134799
ChEMBL
CHEMBL1909286
Wikipedia
Phenoxypropazine

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility6.03 mg/mLALOGPS
logP1.37ALOGPS
logP1.25ChemAxon
logS-1.4ALOGPS
pKa (Strongest Basic)5.45ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area47.28 Å2ChemAxon
Rotatable Bond Count4ChemAxon
Refractivity59.87 m3·mol-1ChemAxon
Polarizability18.67 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Phenol ethers
Sub Class
Not Available
Direct Parent
Phenol ethers
Alternative Parents
Phenoxy compounds / Alkyl aryl ethers / Alkylhydrazines / Organopnictogen compounds / Hydrocarbon derivatives
Substituents
Phenoxy compound / Phenol ether / Alkyl aryl ether / Monocyclic benzene moiety / Alkylhydrazine / Ether / Organic nitrogen compound / Organic oxygen compound / Organopnictogen compound / Hydrocarbon derivative
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available

Drug created on October 23, 2015 22:12 / Updated on December 01, 2017 16:14